Impact of a novel prognostic model on allogeneic hematopoietic stem cell transplantation outcomes in patients with CMML
JY Zhou, S Wang, HL Yuan, YJ Xu… - American Journal of …, 2023 - Wiley Online Library
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell malignancy,
and allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is the only curable …
and allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is the only curable …
[HTML][HTML] Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia
Chronic myelomonocytic leukemia (CMML) is a clonal disorder of aging hematopoietic stem
cells characterized by overlapping features of myeloproliferation and myelodysplasia 1, with …
cells characterized by overlapping features of myeloproliferation and myelodysplasia 1, with …
Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia
K Motohashi, S Fujisawa, N Doki… - Leukemia & …, 2018 - Taylor & Francis
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment
for chronic myelomonocytic leukemia (CMML); however, factors predicting allo-HSCT …
for chronic myelomonocytic leukemia (CMML); however, factors predicting allo-HSCT …
[HTML][HTML] Allogeneic hematopoietic cell transplantation for adult chronic myelomonocytic leukemia
Allogeneic hematopoietic cell transplantation (HCT) is potentially curative for patients with
chronic myelomonocytic leukemia (CMML); however, few data exist regarding prognostic …
chronic myelomonocytic leukemia (CMML); however, few data exist regarding prognostic …
[HTML][HTML] Long-term survival benefit after allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia
N Gagelmann, R Bogdanov, F Stölzel… - … and Cellular Therapy, 2021 - Elsevier
The critical question in the management of chronic myelomonocytic leukemia (CMML) is
which patients may benefit from allogeneic hematopoietic cell transplantation (allo-HCT) …
which patients may benefit from allogeneic hematopoietic cell transplantation (allo-HCT) …
Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: a nationwide …
H Itonaga, M Iwanaga, K Aoki, J Aoki, K Ishiyama… - Leukemia research, 2016 - Elsevier
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a therapeutic option that
may lead to improved outcomes in patients with chronic myelomonocytic leukemia (CMML) …
may lead to improved outcomes in patients with chronic myelomonocytic leukemia (CMML) …
[HTML][HTML] EASIX and CPSS Cytogenetics score-based composite risk model for patients with CMML undergoing allogeneic transplant
A Baranwal, A Mangaonkar, MV Shah… - Bone Marrow …, 2024 - nature.com
Allogeneic stem cell transplant (alloSCT) remains the only potentially curative option for
patients with chronic myelomonocytic leukemia (CMML). Studies evaluating alloSCT …
patients with chronic myelomonocytic leukemia (CMML). Studies evaluating alloSCT …
Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis
M Robin, LC de Wreede, E Padron… - Blood, The Journal …, 2022 - ashpublications.org
To determine the survival benefit of allogeneic hematopoietic cell transplantation (allo-HCT)
in chronic myelomonocytic leukemias (CMML), we assembled a retrospective cohort of …
in chronic myelomonocytic leukemias (CMML), we assembled a retrospective cohort of …
[HTML][HTML] Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia
We evaluated the outcomes of allogeneic hematopoietic cell transplantation (HCT) in 43
patients with chronic myelomonocytic leukemia. Patients were classified according to the …
patients with chronic myelomonocytic leukemia. Patients were classified according to the …
[HTML][HTML] Prognostic impact of donor source on allogeneic hematopoietic stem cell transplantation outcomes in adults with chronic myelomonocytic leukemia: a …
H Itonaga, K Aoki, J Aoki, T Ishikawa, K Ishiyama… - Biology of Blood and …, 2018 - Elsevier
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapeutic
option for patients with chronic myelomonocytic leukemia (CMML). We retrospectively …
option for patients with chronic myelomonocytic leukemia (CMML). We retrospectively …